Loading…

Intestinal absorption, metabolism, and excretion of (–)-epicatechin in healthy humans assessed by using an intestinal perfusion technique123

(–)-Epicatechin is a dietary flavonoid present in many foods that affects vascular function, but its action is limited by incomplete absorption, conjugation, and metabolism. Factors that influence this activity may be attributed to instability in the gastrointestinal lumen, low permeability across t...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of clinical nutrition 2013-10, Vol.98 (4), p.924-933
Main Authors: Actis-Goretta, Lucas, Lévèques, Antoine, Rein, Maarit, Teml, Alexander, Schäfer, Christian, Hofmann, Ute, Li, Hequn, Schwab, Matthias, Eichelbaum, Michel, Williamson, Gary
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 933
container_issue 4
container_start_page 924
container_title The American journal of clinical nutrition
container_volume 98
creator Actis-Goretta, Lucas
Lévèques, Antoine
Rein, Maarit
Teml, Alexander
Schäfer, Christian
Hofmann, Ute
Li, Hequn
Schwab, Matthias
Eichelbaum, Michel
Williamson, Gary
description (–)-Epicatechin is a dietary flavonoid present in many foods that affects vascular function, but its action is limited by incomplete absorption, conjugation, and metabolism. Factors that influence this activity may be attributed to instability in the gastrointestinal lumen, low permeability across the intestinal wall, or active efflux from enterocytes and extensive conjugation. With the use of a multilumen perfusion catheter, we investigated the jejunal absorption, systemic availability, metabolism, and intestinal, biliary, and urinary excretion of (–)-epicatechin in humans. In a single-center, randomized, open, controlled study in 8 healthy volunteers, 50 mg purified (–)-epicatechin was perfused into an isolated jejunal segment together with antipyrine as a marker for absorption. (–)-Epicatechin and conjugates were measured in intestinal perfusates, bile, plasma, and urine. Forty-six percent of the dose was recovered in the perfusate either as unchanged (–)-epicatechin (22 mg) or conjugates (0.8 mg); with stability taken into account, this result indicates that ~46% of the dose had apparently been absorbed. The conjugates were predominantly sulfates, which indicated conjugation by sulfotransferases followed by efflux from the enterocytes. In contrast, epicatechin glucuronides were dominant in plasma, bile, and urine. Almost one-half of the (–)-epicatechin is apparently absorbed in the jejunum but with substantial interindividual differences in the extent of absorption. The data suggest that the nature and substitution position of (–)-epicatechin conjugation are major determinants of the metabolic fate in the body, influencing whether the compound is effluxed into the lumen or absorbed into the blood and subsequently excreted.
doi_str_mv 10.3945/ajcn.113.065789
format article
fullrecord <record><control><sourceid>elsevier</sourceid><recordid>TN_cdi_elsevier_sciencedirect_doi_10_3945_ajcn_113_065789</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002916523052607</els_id><sourcerecordid>S0002916523052607</sourcerecordid><originalsourceid>FETCH-elsevier_sciencedirect_doi_10_3945_ajcn_113_0657893</originalsourceid><addsrcrecordid>eNqlkMFKxDAQhoMoWFfPXnNU2HaTZtttz6Ksd-8hTad2ljatnVTcm0_gxTf0SUxRfAHhh2H-mfkHPsaupUhUuc025mBdIqVKRJ7tivKERbJURaxSsTtlkRAijUuZZ-fsgugghEy3RR6xj0fngTw603FT0TCNHge35j14Uw0dUr_mxtUc3uwEy4gPDb_5ev-8jWFEazzYFh0PasF0vj3ydu6NI26IIKjm1ZHPhO45xIS1v2cjTE3wQ-AS4fBlBpmqS3bWmI7g6reuWPlw_3S3jyE0rwiTJovgLNQ4gfW6HlBLoRcAegGgAwD9A0D95_YbFtVs1w</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Intestinal absorption, metabolism, and excretion of (–)-epicatechin in healthy humans assessed by using an intestinal perfusion technique123</title><source>ScienceDirect</source><creator>Actis-Goretta, Lucas ; Lévèques, Antoine ; Rein, Maarit ; Teml, Alexander ; Schäfer, Christian ; Hofmann, Ute ; Li, Hequn ; Schwab, Matthias ; Eichelbaum, Michel ; Williamson, Gary</creator><creatorcontrib>Actis-Goretta, Lucas ; Lévèques, Antoine ; Rein, Maarit ; Teml, Alexander ; Schäfer, Christian ; Hofmann, Ute ; Li, Hequn ; Schwab, Matthias ; Eichelbaum, Michel ; Williamson, Gary</creatorcontrib><description>(–)-Epicatechin is a dietary flavonoid present in many foods that affects vascular function, but its action is limited by incomplete absorption, conjugation, and metabolism. Factors that influence this activity may be attributed to instability in the gastrointestinal lumen, low permeability across the intestinal wall, or active efflux from enterocytes and extensive conjugation. With the use of a multilumen perfusion catheter, we investigated the jejunal absorption, systemic availability, metabolism, and intestinal, biliary, and urinary excretion of (–)-epicatechin in humans. In a single-center, randomized, open, controlled study in 8 healthy volunteers, 50 mg purified (–)-epicatechin was perfused into an isolated jejunal segment together with antipyrine as a marker for absorption. (–)-Epicatechin and conjugates were measured in intestinal perfusates, bile, plasma, and urine. Forty-six percent of the dose was recovered in the perfusate either as unchanged (–)-epicatechin (22 mg) or conjugates (0.8 mg); with stability taken into account, this result indicates that ~46% of the dose had apparently been absorbed. The conjugates were predominantly sulfates, which indicated conjugation by sulfotransferases followed by efflux from the enterocytes. In contrast, epicatechin glucuronides were dominant in plasma, bile, and urine. Almost one-half of the (–)-epicatechin is apparently absorbed in the jejunum but with substantial interindividual differences in the extent of absorption. The data suggest that the nature and substitution position of (–)-epicatechin conjugation are major determinants of the metabolic fate in the body, influencing whether the compound is effluxed into the lumen or absorbed into the blood and subsequently excreted.</description><identifier>ISSN: 0002-9165</identifier><identifier>EISSN: 1938-3207</identifier><identifier>DOI: 10.3945/ajcn.113.065789</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>The American journal of clinical nutrition, 2013-10, Vol.98 (4), p.924-933</ispartof><rights>2013 American Society for Nutrition.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002916523052607$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids></links><search><creatorcontrib>Actis-Goretta, Lucas</creatorcontrib><creatorcontrib>Lévèques, Antoine</creatorcontrib><creatorcontrib>Rein, Maarit</creatorcontrib><creatorcontrib>Teml, Alexander</creatorcontrib><creatorcontrib>Schäfer, Christian</creatorcontrib><creatorcontrib>Hofmann, Ute</creatorcontrib><creatorcontrib>Li, Hequn</creatorcontrib><creatorcontrib>Schwab, Matthias</creatorcontrib><creatorcontrib>Eichelbaum, Michel</creatorcontrib><creatorcontrib>Williamson, Gary</creatorcontrib><title>Intestinal absorption, metabolism, and excretion of (–)-epicatechin in healthy humans assessed by using an intestinal perfusion technique123</title><title>The American journal of clinical nutrition</title><description>(–)-Epicatechin is a dietary flavonoid present in many foods that affects vascular function, but its action is limited by incomplete absorption, conjugation, and metabolism. Factors that influence this activity may be attributed to instability in the gastrointestinal lumen, low permeability across the intestinal wall, or active efflux from enterocytes and extensive conjugation. With the use of a multilumen perfusion catheter, we investigated the jejunal absorption, systemic availability, metabolism, and intestinal, biliary, and urinary excretion of (–)-epicatechin in humans. In a single-center, randomized, open, controlled study in 8 healthy volunteers, 50 mg purified (–)-epicatechin was perfused into an isolated jejunal segment together with antipyrine as a marker for absorption. (–)-Epicatechin and conjugates were measured in intestinal perfusates, bile, plasma, and urine. Forty-six percent of the dose was recovered in the perfusate either as unchanged (–)-epicatechin (22 mg) or conjugates (0.8 mg); with stability taken into account, this result indicates that ~46% of the dose had apparently been absorbed. The conjugates were predominantly sulfates, which indicated conjugation by sulfotransferases followed by efflux from the enterocytes. In contrast, epicatechin glucuronides were dominant in plasma, bile, and urine. Almost one-half of the (–)-epicatechin is apparently absorbed in the jejunum but with substantial interindividual differences in the extent of absorption. The data suggest that the nature and substitution position of (–)-epicatechin conjugation are major determinants of the metabolic fate in the body, influencing whether the compound is effluxed into the lumen or absorbed into the blood and subsequently excreted.</description><issn>0002-9165</issn><issn>1938-3207</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqlkMFKxDAQhoMoWFfPXnNU2HaTZtttz6Ksd-8hTad2ljatnVTcm0_gxTf0SUxRfAHhh2H-mfkHPsaupUhUuc025mBdIqVKRJ7tivKERbJURaxSsTtlkRAijUuZZ-fsgugghEy3RR6xj0fngTw603FT0TCNHge35j14Uw0dUr_mxtUc3uwEy4gPDb_5ev-8jWFEazzYFh0PasF0vj3ydu6NI26IIKjm1ZHPhO45xIS1v2cjTE3wQ-AS4fBlBpmqS3bWmI7g6reuWPlw_3S3jyE0rwiTJovgLNQ4gfW6HlBLoRcAegGgAwD9A0D95_YbFtVs1w</recordid><startdate>201310</startdate><enddate>201310</enddate><creator>Actis-Goretta, Lucas</creator><creator>Lévèques, Antoine</creator><creator>Rein, Maarit</creator><creator>Teml, Alexander</creator><creator>Schäfer, Christian</creator><creator>Hofmann, Ute</creator><creator>Li, Hequn</creator><creator>Schwab, Matthias</creator><creator>Eichelbaum, Michel</creator><creator>Williamson, Gary</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope></search><sort><creationdate>201310</creationdate><title>Intestinal absorption, metabolism, and excretion of (–)-epicatechin in healthy humans assessed by using an intestinal perfusion technique123</title><author>Actis-Goretta, Lucas ; Lévèques, Antoine ; Rein, Maarit ; Teml, Alexander ; Schäfer, Christian ; Hofmann, Ute ; Li, Hequn ; Schwab, Matthias ; Eichelbaum, Michel ; Williamson, Gary</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-elsevier_sciencedirect_doi_10_3945_ajcn_113_0657893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Actis-Goretta, Lucas</creatorcontrib><creatorcontrib>Lévèques, Antoine</creatorcontrib><creatorcontrib>Rein, Maarit</creatorcontrib><creatorcontrib>Teml, Alexander</creatorcontrib><creatorcontrib>Schäfer, Christian</creatorcontrib><creatorcontrib>Hofmann, Ute</creatorcontrib><creatorcontrib>Li, Hequn</creatorcontrib><creatorcontrib>Schwab, Matthias</creatorcontrib><creatorcontrib>Eichelbaum, Michel</creatorcontrib><creatorcontrib>Williamson, Gary</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><jtitle>The American journal of clinical nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Actis-Goretta, Lucas</au><au>Lévèques, Antoine</au><au>Rein, Maarit</au><au>Teml, Alexander</au><au>Schäfer, Christian</au><au>Hofmann, Ute</au><au>Li, Hequn</au><au>Schwab, Matthias</au><au>Eichelbaum, Michel</au><au>Williamson, Gary</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intestinal absorption, metabolism, and excretion of (–)-epicatechin in healthy humans assessed by using an intestinal perfusion technique123</atitle><jtitle>The American journal of clinical nutrition</jtitle><date>2013-10</date><risdate>2013</risdate><volume>98</volume><issue>4</issue><spage>924</spage><epage>933</epage><pages>924-933</pages><issn>0002-9165</issn><eissn>1938-3207</eissn><abstract>(–)-Epicatechin is a dietary flavonoid present in many foods that affects vascular function, but its action is limited by incomplete absorption, conjugation, and metabolism. Factors that influence this activity may be attributed to instability in the gastrointestinal lumen, low permeability across the intestinal wall, or active efflux from enterocytes and extensive conjugation. With the use of a multilumen perfusion catheter, we investigated the jejunal absorption, systemic availability, metabolism, and intestinal, biliary, and urinary excretion of (–)-epicatechin in humans. In a single-center, randomized, open, controlled study in 8 healthy volunteers, 50 mg purified (–)-epicatechin was perfused into an isolated jejunal segment together with antipyrine as a marker for absorption. (–)-Epicatechin and conjugates were measured in intestinal perfusates, bile, plasma, and urine. Forty-six percent of the dose was recovered in the perfusate either as unchanged (–)-epicatechin (22 mg) or conjugates (0.8 mg); with stability taken into account, this result indicates that ~46% of the dose had apparently been absorbed. The conjugates were predominantly sulfates, which indicated conjugation by sulfotransferases followed by efflux from the enterocytes. In contrast, epicatechin glucuronides were dominant in plasma, bile, and urine. Almost one-half of the (–)-epicatechin is apparently absorbed in the jejunum but with substantial interindividual differences in the extent of absorption. The data suggest that the nature and substitution position of (–)-epicatechin conjugation are major determinants of the metabolic fate in the body, influencing whether the compound is effluxed into the lumen or absorbed into the blood and subsequently excreted.</abstract><pub>Elsevier Inc</pub><doi>10.3945/ajcn.113.065789</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9165
ispartof The American journal of clinical nutrition, 2013-10, Vol.98 (4), p.924-933
issn 0002-9165
1938-3207
language eng
recordid cdi_elsevier_sciencedirect_doi_10_3945_ajcn_113_065789
source ScienceDirect
title Intestinal absorption, metabolism, and excretion of (–)-epicatechin in healthy humans assessed by using an intestinal perfusion technique123
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T21%3A32%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intestinal%20absorption,%20metabolism,%20and%20excretion%20of%20(%E2%80%93)-epicatechin%20in%20healthy%20humans%20assessed%20by%20using%20an%20intestinal%20perfusion%20technique123&rft.jtitle=The%20American%20journal%20of%20clinical%20nutrition&rft.au=Actis-Goretta,%20Lucas&rft.date=2013-10&rft.volume=98&rft.issue=4&rft.spage=924&rft.epage=933&rft.pages=924-933&rft.issn=0002-9165&rft.eissn=1938-3207&rft_id=info:doi/10.3945/ajcn.113.065789&rft_dat=%3Celsevier%3ES0002916523052607%3C/elsevier%3E%3Cgrp_id%3Ecdi_FETCH-elsevier_sciencedirect_doi_10_3945_ajcn_113_0657893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true